XOOMAR

Rockwell Medical (RMTI)

Rockwell Medical on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.

Download CSV

70K

Short interest

settlement 2026-10-15

2.2

Days to cover

-1.3 days vs prior

17.2%

Short share of volume

2026-11-02

1,306

Fails to deliver

settlement 2026-10-14

Wed 11 Nov

Next earnings

estimated date

-$8K

Insider flow, 90 days

0 buys, 1 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in RMTI is 70,068 shares, down 19,801 shares over the last month. Over the last 48 readings it ranged from 70,068 shares (15 October 2026) to 1,545,437 shares (15 September 2025). The latest reading sits at the bottom of that range. At the reported average volume of 32K shares a day that is 2.2 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/rmti" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-1570,068-1.0%31,6662.21
2026-09-3070,807-21.2%19,9353.55
2026-09-1589,869-3.4%19,5754.59
2026-08-3192,980+5.6%27,1573.42
2026-08-1488,030-10.6%32,9242.67
2026-07-3198,502+15.2%33,0982.98
2026-07-1585,486-89.4%42,9681.99
2026-06-30803,271+9.4%396,2182.03
2026-06-15734,278+91.2%386,6861.90
2026-05-29383,990-21.8%251,7961.53
2026-05-15491,297+26.8%297,5271.65
2026-04-30387,448-60.9%211,6361.83
2026-04-15990,637+33.3%165,8095.97
2026-03-31743,232-19.0%340,3172.18
2026-03-13917,373+7.3%265,1033.46
2026-02-27854,903+4.4%247,1053.46
2026-02-13818,620+19.3%278,8142.94
2026-01-30686,242+18.2%2,811,3951.00
2026-01-15580,562-32.0%204,4812.84
2025-12-31853,816+44.1%261,8243.26
2025-12-15592,459-33.4%206,3942.87
2025-11-28888,853-6.5%250,8883.54
2025-11-14950,566-8.0%463,2862.05
2025-10-311,033,506-4.4%392,2602.63
2025-10-151,080,810-18.0%669,9931.61
2025-09-301,318,126-14.7%1,452,4201.00
2025-09-151,545,437+51.0%2,933,0171.00
2025-08-291,023,721+484.8%3,270,8391.00
2025-08-15175,071+72.2%190,5831.00
2025-07-31101,698-33.2%230,4511.00
2025-07-15152,280-11.2%674,9541.00
2025-06-30171,468+1.5%237,5841.00
2025-06-13168,973+3.9%164,5691.03
2025-05-30162,630-14.9%186,3101.00
2025-05-15191,155-1.5%311,9361.00
2025-04-30194,059-45.9%135,9221.43
2025-04-15358,470-27.4%256,3741.40
2025-03-31493,828-5.1%427,9921.15
2025-03-14520,325+13.1%185,6542.80
2025-02-28459,975+4.8%196,8902.34
2025-02-14438,766-13.0%292,3691.50
2025-01-31504,200-12.2%224,0192.25
2025-01-15574,049-7.0%342,0691.68
2024-12-31617,463-28.5%493,3371.25
2024-12-13863,901-12.4%589,7011.46
2024-11-29985,773-11.7%805,7421.22
2024-11-151,116,829+24.9%1,647,2821.00
2024-10-31893,869+8.6%359,5212.49

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of RMTI volume is 17.2%, down 14.5 points over the last five sessions. Over the last 30 readings it ranged from 4.8% (20 October 2026) to 70.3% (23 September 2026). The latest reading is 23.2 points below the 30-session average of 40.4%, on 5K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-029335K17.2%0
2026-10-304K10K39.5%0
2026-10-296202K29.3%0
2026-10-284K13K28.9%0
2026-10-274K17K21.0%200
2026-10-263K9K31.7%0
2026-10-235K9K56.0%0
2026-10-221K2K48.2%0
2026-10-2111K17K63.1%0
2026-10-204139K4.8%0
2026-10-194K8K50.2%0
2026-10-1616K65K24.1%0
2026-10-158K37K22.5%0
2026-10-141K6K21.5%0
2026-10-1313K19K69.5%0
2026-10-128K32K24.7%0
2026-10-096965K15.1%0
2026-10-081K2K67.3%0
2026-10-073K9K34.5%477
2026-10-062K41K5.7%0
2026-10-051K2K49.8%0
2026-10-023K4K62.8%100
2026-10-012K5K44.6%4
2026-09-305K15K32.9%0
2026-09-293K5K63.7%0
2026-09-284K6K65.6%0
2026-09-252K3K58.8%0
2026-09-243K10K33.7%0
2026-09-233K5K70.3%0
2026-09-225K10K55.6%130

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 14 October 2026, the fails-to-deliver balance in RMTI is 1,306 shares, up 976 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (16 July 2026) to 4,139 shares (30 July 2026).

SettlementShares failedPriceValue
2026-10-141,306$7.85$10K
2026-10-05330$8.55$3K
2026-09-29799$8.63$7K
2026-09-28199$8.37$2K
2026-09-2411$8.57$94
2026-09-2254$8.70$470
2026-09-21102$8.07$823
2026-09-18696$7.91$6K
2026-09-15240$7.78$2K
2026-09-112,611$8.04$21K
2026-09-085$7.99$40
2026-08-2111$7.64$84
2026-08-20866$7.50$6K
2026-08-1853$7.49$397
2026-08-13440$7.51$3K
2026-08-10575$7.14$4K
2026-08-071,472$7.16$11K
2026-08-06528$7.26$4K
2026-08-051,638$7.57$12K
2026-07-304,139$6.88$28K
2026-07-28453$7.00$3K
2026-07-213,602$6.30$23K
2026-07-201,609$6.13$10K
2026-07-171,040$5.73$6K
2026-07-161$5.64$6
2026-07-152,137$5.63$12K
2026-07-142,400$5.67$14K
2026-07-13981$5.61$6K
2026-07-102$5.77$12
2026-07-09664$5.63$4K

Insider trades

SEC Form 4, newest first. JSON

Insiders at RMTI reported 1 open-market sell worth $8K in the last 90 days and no open-market buys. Latest filing: Strobeck Mark (President and CEO) on 2026-10-01.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-10-01Strobeck MarkPresident and CEOSell1K$8.42$8K61K
2026-07-01Radie Robert SDirectorGrant10K$0.00$024K
2026-07-01TIMMINS MEGAN C.EVP, CLO & SecretaryGrant15K$0.00$031K
2026-07-01Strobeck MarkPresident and CEOGrant30K$0.00$062K
2026-07-01Nissenson AllenDirectorGrant10K$0.00$024K
2026-07-01Neri JesseSVP and CFOGrant15K$0.00$027K
2026-07-01Lau JoanDirectorGrant10K$0.00$021K
2026-07-01Hunter HeatherChief Operating OfficerGrant15K$0.00$028K
2026-07-01Dawson Joseph HDirectorGrant10K$0.00$012K
2026-07-01Chole TimothySVP and CCOGrant15K$0.00$027K
2026-07-01COOPER JOHN GDirectorGrant10K$0.00$024K
2026-03-14TIMMINS MEGAN C.See RemarksTax withholding4K$0.90$3K162K
2026-03-14Strobeck MarkPresident and CEOTax withholding7K$0.90$7K323K
2026-03-14Neri JesseSVP and CFOTax withholding2K$0.90$2K122K
2026-03-14Hunter HeatherChief Operating OfficerTax withholding2K$0.90$2K130K
2026-03-14Chole TimothySVP and CCOTax withholding2K$0.90$2K123K
2026-01-02Neri JesseSVP and CFOSell886$0.84$740125K
2026-01-02Hunter HeatherChief Operating OfficerSell3K$0.84$2K133K
2025-11-18COOPER JOHN GDirectorSell5K$0.87$4K140K
2025-11-17Dawson Joseph HDirectorGrant25K$0.00$025K
2025-10-01Strobeck MarkPresident and CEOSell7K$1.19$8K331K
2025-10-01Neri JesseSVP and CFOSell886$1.19$1K126K
2025-10-01Chole TimothySVP and CCOSell3K$1.19$3K125K
2025-10-01Hunter HeatherSVP, Chief Operating OfficerSell3K$1.19$3K135K
2025-07-01Strobeck MarkPresident and CEOSell7K$0.82$6K338K
2025-07-01Neri JesseSVP and CFOSell886$0.82$727127K
2025-07-01Chole TimothySVP and CCOSell3K$0.82$2K128K
2025-05-20Strobeck MarkPresident and CEOGrant220K$0.00$0345K
2025-05-20TIMMINS MEGAN C.EVP, CLO and SecretaryGrant98K$0.00$0166K
2025-05-20Neri JesseSVP, FINANCE AND CFOGrant98K$0.00$0128K
2025-05-20Chole TimothySVP, Chief Commercial OfficerGrant85K$0.00$0131K
2025-05-20Smiley Andrea HeslinDirectorGrant50K$0.00$0142K
2025-05-20Radie Robert SDirectorGrant50K$0.00$0144K
2025-05-20RAVICH MARK HDirectorGrant50K$0.00$0149K
2025-05-20Nissenson AllenDirectorGrant50K$0.00$0143K
2025-05-20COOPER JOHN GDirectorGrant50K$0.00$0145K
2025-05-20Lau JoanDirectorGrant50K$0.00$0113K
2025-04-11Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.09$2K3.6M
2025-04-11Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.06$2K3.5M
2025-04-11Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.10$2K3.5M
2025-04-11Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.08$2K3.5M
2025-04-11Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.08$2K3.5M
2025-04-11Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.08$2K3.5M
2025-04-11Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.07$2K3.5M
2025-04-11Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.07$2K3.5M
2025-04-11Irrevocable Larson Family Investment TrustTenPercentOwnerBuy4K$1.09$4K3.5M
2025-04-11Irrevocable Larson Family Investment TrustTenPercentOwnerBuy2K$1.09$2K3.5M
2025-04-11Irrevocable Larson Family Investment TrustTenPercentOwnerBuy6K$1.08$6K3.6M
2025-04-11Irrevocable Larson Family Investment TrustTenPercentOwnerBuy1K$1.09$1K3.5M
2025-04-11Irrevocable Larson Family Investment TrustTenPercentOwnerBuy2K$1.08$2K3.5M
2025-04-10Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.09$2K3.5M
2025-04-10Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.06$2K3.5M
2025-04-10Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.06$2K3.5M
2025-04-10Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.04$2K3.5M
2025-04-10Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.05$2K3.5M
2025-04-10Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.04$2K3.5M
2025-04-10Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.07$2K3.5M
2025-04-10Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.08$2K3.5M
2025-04-10Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.08$2K3.5M
2025-04-10Irrevocable Larson Family Investment Trust10% ownerBuy2K$1.05$2K3.5M
2025-04-10Irrevocable Larson Family Investment Trust10% ownerBuy4K$1.08$4K3.5M
2025-04-10Irrevocable Larson Family Investment Trust10% ownerBuy4K$1.06$4K3.5M
2025-04-10Irrevocable Larson Family Investment TrustTenPercentOwnerBuy6K$1.07$6K3.5M
2025-04-10Irrevocable Larson Family Investment TrustTenPercentOwnerBuy7K$1.07$7K3.5M
2025-04-10Irrevocable Larson Family Investment TrustTenPercentOwnerBuy10K$1.10$11K3.5M
2025-04-10Irrevocable Larson Family Investment TrustTenPercentOwnerBuy4K$1.06$4K3.5M
2025-04-10Irrevocable Larson Family Investment TrustTenPercentOwnerBuy2K$1.05$2K3.5M
2025-04-01Chole TimothySVP, Chief Commercial OfficerSell3K$1.08$3K46K
2025-04-01Neri JesseSVP, FINANCE AND CFOSell886$1.10$97530K
2025-04-01Strobeck MarkPresident and CEOSell7K$1.08$7K125K
2025-03-17Strobeck MarkPresident and CEOTax withholding6K$1.77$11K132K
2025-03-17TIMMINS MEGAN C.EVP, CLO and SecretaryTax withholding3K$1.77$6K69K
2025-03-17Chole TimothySVP, Chief Commercial OfficerTax withholding3K$1.77$5K49K
2025-03-14Strobeck MarkPresident and CEOTax withholding7K$1.70$12K138K
2025-03-14TIMMINS MEGAN C.EVP, CLO and SecretaryTax withholding4K$1.70$6K72K
2025-03-14Neri JesseSVP, FINANCE AND CFOTax withholding2K$1.70$4K31K
2025-03-14Chole TimothySVP, Chief Commercial OfficerTax withholding2K$1.70$4K52K
2025-01-02Strobeck MarkPresident and CEOSell2K$2.06$4K145K
2025-01-02Chole TimothySVP, Chief Commercial OfficerSell1K$2.05$2K54K
2024-11-15RAVICH MARK HDirectorSell20K$2.32$46K0
2024-11-15RAVICH MARK HDirectorSell10K$2.40$24K121K
2024-10-01Strobeck MarkPresident and CEOSell2K$3.69$8K147K
2024-10-01Chole TimothySVP, Chief Commercial OfficerSell1K$3.69$4K55K
2024-05-21Nissenson AllenDirectorGrant36K$0.00$093K
2024-05-21Smiley Andrea HeslinDirectorGrant36K$0.00$092K
2024-05-21COOPER JOHN GDirectorGrant36K$0.00$095K
2024-05-21Lau JoanDirectorGrant36K$0.00$063K
2024-05-21RAVICH MARK HDirectorGrant36K$0.00$0109K
2024-05-21Radie Robert SDirectorGrant36K$0.00$094K
2024-03-17TIMMINS MEGAN C.EVP, CLO and SecretaryTax withholding3K$1.40$4K75K
2024-03-17Strobeck MarkPresident and CEOTax withholding6K$1.40$9K149K
2024-03-14TIMMINS MEGAN C.EVP, CLO and SecretaryGrant50K$0.00$079K
2024-03-14Strobeck MarkPresident and CEOGrant100K$0.00$0155K
2024-03-14Neri JesseSVP, FINANCEGrant33K$0.00$033K
2023-10-16Lau JoanDirectorGrant25K$0.00$027K
2023-10-16Lau JoanDirectorGrant25K$0.00$025K
2023-05-23COOPER JOHN GDirectorGrant25K$0.00$0156K
2023-05-23RAVICH MARK HDirectorGrant25K$0.00$0303K
2023-05-23Nissenson AllenDirectorGrant25K$0.00$0124K
2023-05-23Radie Robert SDirectorGrant25K$0.00$0134K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

7 Form 144 notices on file for RMTI worth $28K at the prices reported; 1 in the last 90 days worth $8K. Latest: Strobeck Mark filed on 2026-10-01 to sell 1,000 shares ($8K) from 2026-10-01.

FiledSellerSharesMarket valueOf outstandingSale fromBroker
2026-10-01Strobeck MarkOfficer1K$8K0.025%2026-10-01Raymond James & Associates, Inc.
2026-01-05Neri JesseOfficer886$7120.002%2026-01-02Raymond James & Associates
2026-01-02Hunter HeatherOfficer3K$2K0.007%2026-01-02Raymond James & Associates
2025-11-18COOPER JOHN GDirector5K$5K0.013%2025-11-18Fidelity Brokerage Services LLC
2025-10-01Strobeck MarkOfficer7K$8K0.020%2025-10-01Raymond James & Associates
2025-10-01Neri JesseOfficer886$1K0.003%2025-10-01Raymond James & Associates
2025-10-01Chole TimothyOfficer3K$3K0.008%2025-10-01Raymond James & Associates

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

No holder on file reports 5% or more of RMTI in its latest filing.

FiledFormHolderSharesOf classEvent
2025-11-1413G/Ano. 1Armistice Capital, LLCinvestment adviser, other entity1.8M5.0%2025-09-30
2025-11-1413G/Ano. 1Steven Boydparent holding company, individual1.8M5.0%2025-09-30

13F holders

Tracked managers holding RMTI at their latest 13F. JSON

1 of the 30 tracked managers held RMTI at their latest 13F, $198K in total at quarter-end prices. Renaissance Technologies is the largest at $198K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 1 cut.

FundQuarterSharesValueOf portfolioChange in shares
Renaissance Technologies2026-06-30360K$198K0.00%-279K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Rockwell Medical in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Rockwell Medical (RMTI), SEC CIK 1041024, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
Planned sales
SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-01.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2025-11-14.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-13.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-01.JSON and CSV
Company record
EDGAR filing index for CIK 1041024Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of RMTI is sold short?
70,068 shares were held short at the 2026-10-15 settlement, 2.2 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is RMTI's daily short volume?
On 2026-11-02, 933 of the 5,413 RMTI shares reported to FINRA were sold short, 17.2% of the day's reported volume. Short volume is a flow for one day, not a position.
Does RMTI have fails to deliver?
The SEC's latest file shows 1,306 RMTI shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are RMTI insiders buying or selling?
Insiders at RMTI reported 1 open-market sell worth $8K in the last 90 days and no open-market buys. Latest filing: Strobeck Mark (President and CEO) on 2026-10-01.
Have RMTI insiders filed to sell?
7 Form 144 notices on file for RMTI worth $28K at the prices reported; 1 in the last 90 days worth $8K. Latest: Strobeck Mark filed on 2026-10-01 to sell 1,000 shares ($8K) from 2026-10-01.
Who owns 5% or more of RMTI?
No holder on file reports 5% or more of RMTI in its latest filing.
Which tracked 13F managers own RMTI?
1 of the 30 tracked 13F managers held RMTI shares at their latest filing, $198K in all. The largest: Renaissance Technologies (360K shares, $198K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.